Unicef: Democratic Republic of the Congo Starts Mpox Vaccination in High-Priority Provinces

Published on October 15, 2024

The Democratic Republic of the Congo (DRC) has started vaccinating vulnerable groups against mpox in high-priority provinces. Supported by UNICEF, WHO, Gavi, and Africa CDC, 265,000 doses of the MVA-BN vaccine have been delivered. The vaccination campaign focuses on protecting health workers, contacts of mpox cases, and immunocompromised individuals. Mpox has heavily affected children, with over 30,000 suspected cases and 900 deaths this year. UNICEF also emphasizes community engagement, infection prevention, and addressing related health challenges in the affected provinces. To read more, click the link below!

Access the Article!

 
 
Other news

[CALL FOR ABSTRACTS!] GVIRF Vaccine and Research Innovation Meeting

October 15, 2024
The Global Vaccine and Immunization Research Forum (GVIRF) is calling for abstracts for its March 2024 event in Rio de Janeiro, Brazil. Organized by the Bill & Melinda Gates Foundation, the U.S. National Institute of Allergy and Infectious Diseases, and WHO, the forum will focus on vaccine research and innovation aligned with Immunization Agenda 2030. The deadline for submissions is November 22, 2

Introducing the Vaccination Acceptance Research Network (VARN)

November 12, 2024
We are excited to share that we are launching the Vaccination Acceptance Research Network (VARN) Online Community through a dedicated learning group on the Boost Community platform!  In 2019, Sabin stood up the VARN, and it has since expanded to over 850 members from more than 95 countries. As those of you who are already VARN members know, the VARN programing focuses on evidence-generation from b